Dataset Information


Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.

ABSTRACT: We aimed to identify prognostic signature based on autophagy-related genes (ARGs) for breast cancer patients. The datasets of breast cancer were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Least absolute shrinkage and selection operator (LASSO) Cox regression was conducted to construct multiple-ARG risk signature. In total, 32 ARGs were identified as differentially expressed between tumors and adjacent normal tissues based on TCGA. Six ARGs (IFNG, TP63, PPP1R15A, PTK6, EIF4EBP1 and NKX2-3) with non-zero coefficient were selected from the 32 ARGs using LASSO regression. The 6-ARG signature divided patients into high-and low-risk group. Survival analysis indicated that low-risk group had longer survival time than high-risk group. We further validated the 6-ARG signature using dataset from GEO and found similar results. We analyzed the associations between ARGs and breast cancer survival in TCGA and nine GEO datasets, and obtained 170 ARGs with significant associations. EIF4EBP1, FOS and FAS were the top three ARGs with highest numbers of significant associations. EIF4EBP1 may be a key ARG which had a higher expression level in patients with more malignant molecular subtypes and higher grade breast cancer. In conclusion, our 6-ARG signature was of significance in predicting of overall survival of patients with breast cancer. EIF4EBP1 may be a key ARG associated with breast cancer survival.


PROVIDER: S-EPMC7391974 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2021-01-01 | S-EPMC7910047 | BioStudies
2020-01-01 | S-EPMC7653605 | BioStudies
2020-01-01 | S-EPMC7417718 | BioStudies
2020-01-01 | S-EPMC7821871 | BioStudies
2020-01-01 | S-EPMC7377895 | BioStudies
2020-01-01 | S-EPMC7763234 | BioStudies
2020-01-01 | S-EPMC7604433 | BioStudies
2020-01-01 | S-EPMC7900625 | BioStudies
2019-01-01 | S-EPMC6997532 | BioStudies
2020-01-01 | S-EPMC7596585 | BioStudies